Veterans Health Administration Novel Therapeutics Preparedness Act
Committee on Veterans' Affairs. Hearings held.
Email me when S 4220 moves
Committee action, floor votes, amendments and hearings. Free, no card, no password.
Already have an account? Track S 4220. By continuing you agree to the Terms and Privacy Policy.
Legislative status
- Introduced
- In Committee
- Reported by Committee
- Floor Vote Scheduled
- Passed One Chamber
- Passed Both Chambers
- Sent to Executive
- Signed into Law
Summary
The bill establishes an Office of Novel Therapeutics within the VA Health Administration to develop policies, training, and infrastructure for new FDA‑reviewed treatments such as psychedelic‑assisted therapy. It affects veterans receiving mental‑health care, VA clinicians, and the VA system by coordinating research, clinical rollout, and safety monitoring. The goal is to ensure veterans can safely access cutting‑edge therapies while the VA remains ready for regulatory approval.
AI-generated summary — may be incomplete or inaccurate. Verify against the official bill text.
Ask about S 4220
3 free questions a day, no accountHistory
- Committee on Veterans' Affairs. Hearings held.
- Read twice and referred to the Committee on Veterans' Affairs.
- Introduced in Senate
Sponsors
- Sen. Sheehy, Tim [R-MT] (R) · sponsor
- Sen. Boozman, John [R-AR] (R)
- Sen. Duckworth, Tammy [D-IL] (D)
- Sen. Gallego, Ruben [D-AZ] (D)
Similar bills in other states
Loading the map of where bills like this one were filed.
Share
Writing about this bill? Add a live status widget to your site or newsletter. It updates as the bill moves.
Track this bill
Get an email when S 4220 moves: committee action, floor votes, amendments and hearings. Free, no card.
Track S 4220 freeOr ask your AI assistant about S 4220 directly:
Add to Claude, ChatGPT or Cursor